Related Experiment Video
Updated: Mar 26, 2026

06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
28.0K
Predicting glioblastoma response to bevacizumab through marker profiling?
1Neurology Clinic, University Hospital Heidelberg and CCU Neurooncology, German Cancer Research Center, Heidelberg, Germany.
Neuro-Oncology
|January 25, 2016
Abstract
No abstract available in PubMed .

